| Aktie | Ticker | Breite | GCS | 2025/Q3 | |||
|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 44.506.160 $ | +2.312.824 $ | +31,6 % | 4 | ||||
| Entrada Therapeutics, Inc. | TRDA | → 0 | Neutral | 25.410.160 $ | -4.030.577 $ | -13,7 % | 1 |
| Dyne Therapeutics, Inc. | DYN | → 0 | Neutral | 8.632.056 $ | +2.135.836 $ | +32,9 % | 1 |
| Werewolf Therapeutics, Inc. | HOWL | → 0 | Schwach | 8.490.424 $ | +3.792.677 $ | +80,7 % | 1 |
| Repare Therapeutics Inc. | → 0 | 1.973.520 $ | +414.888 $ | +26,6 % | 1 | ||
| 44.506.160 $ | +2.312.824 $ | +31,6 % | 4 | ||||